Home
>
US Stocks
>
89bio Inc
89bio Inc
ETNB

89bio Inc (ETNB)

$17.320.86%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$17.96
Today Low/High$17.32 / $17.96
52 Week Low/High$14.7 / $28.28
Market Cap$350.33M

Company Details

89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is a specifically engineered glycoPEGylated analog of FGF21. BIO89-100 is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). 89bio is headquartered in San Francisco with operations in Herzliya, Israel.
Organisation89bio Inc
Employees27
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is 89bio Inc (ETNB) share price today?

Can Indians buy 89bio Inc (ETNB) shares?

How can I buy 89bio Inc (ETNB) shares from India?

Can Fractional shares of 89bio Inc (ETNB) be purchased?

What are the documents required to start investing in 89bio Inc (ETNB) stocks?

We are a SEBI registered investement advisor